Being tested
Cell therapy or transplant: reset the immune system for lasting remission in relapsing and progressive MS
relapsing and progressive MS · Cell therapy or transplant
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 3
- Running now
- 1
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Cell or transplant, trial | Not a drug-phase study | 1,000 | 2015 | Paper found, not read | Not counted: not randomised |
| BEAT-MS | Phase 3 | 156 | 2020 | Still running | Will count only if it beats natalizumab |
| Cyclophosphamide anhydrous, trial | Not a drug-phase study | 0 | 2023 | Stopped | Not counted: not randomised |
Counted: 0. Will count later: 1. Not counted: 2.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Being tested
Related hypotheses
- Cell therapy or transplant: reset the immune system for lasting remission in NMOSD
- Cell therapy or transplant: reset the immune system for lasting remission in primary progressive MS
- Cell therapy or transplant: reset the immune system for lasting remission in relapsing MS
- Cell therapy or transplant: reset the immune system for lasting remission in secondary progressive MS
- Cell therapy or transplant: reset the immune system for lasting remission in MS (type not specified)
Assembled by software from public sources.